Abstract
To investigate the antibiotic resistance and resistance mechanism of Corynebacterium kroppenstedtii (C. kroppenstedtii) isolated from patients with mastadenitis. Ninety C. kroppenstedtii clinical isolates were obtained from clinical specimens in 2018–2019. Species identification was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Antimicrobial susceptibility testing was performed by the broth microdilution method. The resistance genes were detected using PCR and DNA sequencing. The results of antimicrobial susceptibility testing indicated that the resistance rates of C. kroppenstedtii to erythromycin and clindamycin, ciprofloxacin, tetracycline, and trimethoprim-sulfamethoxazole were 88.9%, 88.9%, 67.8%, 62.2%, and 46.6%, respectively. None of the C. kroppenstedtii isolates was resistant to rifampicin, linezolid, vancomycin, or gentamicin. The gene of erm(X) was detected in all clindamycin and erythromycin-resistant strains. The gene of sul(1) and tet(W) were detected among all trimethoprim sulfamethoxazole-resistant strains and tetracycline-resistant strains, respectively. Furthermore, 1 or 2 amino acid mutations (mainly single mutation) were observed in the gyrA gene among ciprofloxacin-resistant strains.
Data availability
The data analyzed were extracted from our hospital’s lab computer and the computerized patient records. The analysis was done transparently, and the database is available.
Materials availability
The data analyzed were extracted from our hospital’s lab computer and the computerized patient records. The analysis was done transparently, and the database is available.
Code availability
Not applicable.
References
Tauch A, Fernández-Natal I, Soriano F (2016) A microbiological and clinical review on Corynebacterium kroppenstedtii. Int J Infect Dis 48:33–39
Collins MD, Falsen E, Akervall E, Sjöden B, Alvarez A (1998) Corynebacterium kroppenstedtii sp. nov., a novel corynebacterium that does not contain mycolic acids. Int J Syst Bacteriol 48(Pt 4):1449–1454
Johnstone KJ, Robson J, Cherian SG, Wan Sai Cheong J, Kerr K, Bligh JF (2017) Cystic neutrophilic granulomatous mastitis associated with Corynebacterium including Corynebacterium kroppenstedtii. Pathology 49(4):405–412
Yu HJ, Deng H, Ma J, Huang SJ, Yang JM, Huang YF et al (2016) Clinical metagenomic analysis of bacterial communities in breast abscesses of granulomatous mastitis. Int J Infect Dis 53:30–33
Co M, Cheng V, Wei J, Wong S, Chan S, Shek T et al (2018) Idiopathic granulomatous mastitis: a 10-year study from a multicentre clinical database. Pathology 50(7):742–747
Fernández-Natal I, Rodríguez-Lázaro D, Marrodán-Ciordia T, Sáez-Nieto JA, Valdezate S, Rodríguez-Pollán H et al (2016) Characterization and antimicrobial susceptibility of one antibiotic-sensitive and one multidrug-resistant Corynebacterium kroppenstedtii strain isolated from patients with granulomatous mastitis. New Microbes New Infect 14:93–97
Poojary I, Kurian A, Jayalekshmi VA, Devapriya JD, Thirunarayan MA (2017) Corynebacterium species causing breast abscesses among patients attending a tertiary care hospital in Chennai, South India. Infect Dis (Lond) 49(7):528–531
Ersgaard H, Justesen T (1984) Multiresistant lipophilic corynebacteria from clinical specimens. Biochemical reactions and antimicrobial agents susceptibility. Acta Pathol Microbiol Immunol Scand B 92(1):39–43
Weiss K, Laverdière M, Rivest R (1996) Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods. Antimicrob Agents Chemother 40(4):930–933
Martínez-Martínez L, Ortega MC, Suárez AI (1995) Comparison of E-test with broth microdilution and disk diffusion for susceptibility testing of coryneform bacteria. J Clin Microbiol 33(5):1318–1321
Bao R, Gao X, Hu B, Zhou Z (2017) Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a powerful tool for identification of Corynebacterium species. J Thorac Dis 9(9):3239–3245
Alibi S, Ferjani A, Boukadida J, Ruiz de Alegría C, Martínez-Martínez L, Navas J (2017) Evaluation of the VITEK-MS matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for the identification of clinical Corynebacterium species. Rev Esp Quimioter 30(1):57–58
Szemraj M, Kwaszewska A, Szewczyk EM (2018) New gene responsible for resistance of clinical Corynebacteria to macrolide, lincosamide and streptogramin B. Pol J Microbiol 67(2):237–240
Alibi S, Ferjani A, Boukadida J, Cano ME, Fernández-Martínez M, Martínez-Martínez L et al (2017) Occurrence of Corynebacterium striatum as an emerging antibiotic-resistant nosocomial pathogen in a Tunisian hospital. Sci Rep 7(1):9704
Fernández-Natal MI, Soriano F, Ariza-Miguel J, Marrodan-Ciordia T, Acedo A, Metal H (2015) Draft genome sequences of Corynebacterium kroppenstedtii CNM633/14 and CNM632/14, multidrug-resistant and antibiotic-sensitive isolates from nodules of granulomatous mastitis patients. Genome Announc c3(3):e00525–e00515
Sierra JM, Martinez-Martinez L, Vázquez F, Giralt E, Vila J (2005) Relationship between mutations in the gyrA gene and quinolone resistance in clinical isolates of Corynebacterium striatum and Corynebacterium amycolatum. Antimicrob Agents Chemother 49(5):1714–1719
Ramos JN, Valadão TB, Baio P, Mattos-Guaraldi AL, Vieira VV (2020) Novel mutations in the QRDR region gyrA gene in multidrug-resistance Corynebacterium spp. isolates from intravenous sites. Antonie Van Leeuwenhoek 4:589–592
Funding
This work was funded by the National Key Research and Development Program of China (2021YFC2701800 and 2021YFC2701803), the National Natural Science Foundation of China (grant no. 81861138052), the China Antimicrobial Surveillance Network (independent medical grants from Pfizer, 2018QD100), and the Shanghai Antimicrobial Surveillance Network (3030231003). The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.
Author information
Authors and Affiliations
Contributions
The study’s conception and design were prepared by Qin Zhang, Jian Xu, and Fupin Hu. Materials were prepared by Qin Zhang, Peipei Song, Yi Liu, Xuan Zhu, Liyuan Zhang, Jun Zhang, Qin Wang, and Jian Xu. Experimentation, data collection, and analysis were performed by Qin Zhang, Shi Wu, Li Ding, and Qingyu Shi. The first draft of the manuscript was written by Qin Zhang, Jian Xu, and Fupin Hu, and the manuscript was reviewed and edited by Fupin Hu. All the authors approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval
This study was reviewed and approved by the Ethics Committee of Chengdu Women’s and Children’s Central Hospital. Informed consent from patients was not required by the Ethics Committee because there was no contact with patients.
Consent to participate
Informed consent from patients was not required by the Ethics Committee.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, Q., Wu, S., Song, P. et al. Antibiotic resistance and resistance mechanism of Corynebacterium kroppenstedtii isolated from patients with mastadenitis. Eur J Clin Microbiol Infect Dis 42, 525–528 (2023). https://doi.org/10.1007/s10096-023-04558-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-023-04558-0